News

Researchers turn coffee waste into a weapon against Alzheimer's disease
Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...
GE HealthCare’s Vizamyl Receives Expanded FDA Approval for Quantitative Alzheimer’s Amyloid Detection
GE HealthCare Technologies Inc. (NASDAQ: GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...
Death of a partner and financial stress linked to increased risk of Alzheimer's disease, differences in brain structure
Stressful life events can negatively impact brain health. Specifically, grief over the loss of a partner has been linked to alterations in biological processes associated with Alzheimer's disease, ...
MedPage Today2d
Blood Tests Predict Dementia in Down Syndrome
Of the 258 participants, 195 were cognitively asymptomatic, 34 had mild cognitive impairment, 23 had dementia, and six had an ...
MPR2d
FDA Approves Updated Label for Amyloid PET Imaging Agent Amyvid
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets
Eli Lilly and Company (NYSE: LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...
INmune Bio: Hold Rating Based On Path Forward Of XPro In Subset Of AD Patients
INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.
Blood stem cell mutations linked to lower risk of late-onset Alzheimer's disease
A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...
Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...
The EMBO Journal3d
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation - EMBO Molecular Medicine
Microglia activation forms the brain's innate immune response to cerebral pathologies including fibrillar beta‐amyloid (Aβ), i.e., a primary pathology in Alzheimer's disease. TREM2 is a receptor ...